(Q61959735)
Statements
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial (English)
A Straumann
S Conus
P Grzonka
H Kita
G Kephart
C Bussmann
C Beglinger
D A Smith
J Patel